Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 264401 - 264420 out of 498429 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Iceland | (L04AC05) ustekinumab (adm: P) | WEZENLA | stl, 0,5 ml, 1 áfspr, 45 mg, 45mg , 0,5ml | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | AmgenTechnology(Ireland)UC / Vistorhf |
| Iceland | (L04AC05) ustekinumab (adm: P) | Pyzchiva | stl, 1 ml, 1 áfspr, 90 mg, 90mg , 1ml | Retail price with vat |
$0-0 |
$0-0 |
Crohn Disease;Colitis, Ulcerative;Arthritis, Psoriatic | SamsungBioepisNLB.V. / Artasanehf |
| Iceland | (L04AC05) ustekinumab (adm: P) | Stelara | stl, 1 ml, 1 áfpen, 90 mg/penna, 90mg/penna , 1ml | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | Janssen-CilagInternationalN.V. / Vistorhf |
| Iceland | (L04AC05) ustekinumab (adm: P) | Stelara | stl, 1 ml, 1 áf.spr, 90 mg/spr, 90mg/spr , 1ml | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative | Janssen-CilagInternationalN.V. / Vistorhf |
| Iceland | (L04AC05) ustekinumab (adm: P) | WEZENLA | stl, 1 ml, 1 áfpen, 90 mg/penna, 90mg/penna , 1ml | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | AmgenTechnology(Ireland)UC / Vistorhf |
| Iceland | (L04AC05) ustekinumab (adm: P) | WEZENLA | stl, 1 ml, 1 áfspr, 90 mg, 90mg , 1ml | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic;Crohn Disease | AmgenTechnology(Ireland)UC / Vistorhf |
| Iceland | (L04AC07) tocilizumab (adm: P) | RoActemra | irþ, 4 ml, 1 hgl, 20 mg/ml, 20mg/ml , 4ml | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH / Icepharmahf |
| Iceland | (L04AC07) tocilizumab (adm: P) | RoActemra | irþ, 10 ml, 1 hgl, 20 mg/ml, 20mg/ml , 10ml | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH / Icepharmahf |
| Iceland | (L04AC07) tocilizumab (adm: P) | RoActemra | irþ, 20 ml, 1 hgl, 20 mg/ml, 20mg/ml , 20ml | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH / Icepharmahf |
| Iceland | (L04AC07) tocilizumab (adm: P) | RoActemra | stl, 4 áf-penni, 1 pakki, 162 mg, 162mg , 4áf-penni | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH / Icepharmahf |
| Iceland | (L04AC07) tocilizumab (adm: P) | RoActemra | stl, 4 áf.spr, 1 pakki, 162 mg, 162mg , 4áf.spr | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid;Arthritis, Juvenile Rheumatoid;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | RocheRegistrationGmbH / Icepharmahf |
| Iceland | (L04AC10) secukinumab (adm: P) | Cosentyx | stl, 2 áf-penni, 1 pakki, 150 mg, 150mg , 2áf-penni | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd / Vistorhf |
| Iceland | (L04AC10) secukinumab (adm: P) | Cosentyx | stl, 2 ml, 1 áfpen, 300 mg, 300mg , 2ml | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd / Vistorhf |
| Iceland | (L04AC10) secukinumab (adm: P) | Cosentyx | stl, 0,5 ml, 1 áfspr, 75 mg, 75mg , 0,5ml | Retail price with vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing | NovartisEuropharmLtd / Vistorhf |
| Iceland | (L04AC12) brodalumab (adm: P) | Kyntheum | stl, 1,5 ml, 2 áf.spr, 210 mg, 210mg , 1,5ml | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | LEOPharmaA/S / Vistorhf |
| Iceland | (L04AC13) ixekizumab (adm: P) | Taltz | stl, 1 ml, 1 áfpen, 80 mg, 80mg , 1ml | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis | EliLillyandCompany(Ireland)Limited / Icepharmahf |
| Iceland | (L04AC16) guselkumab (adm: P) | Tremfya | stl, 1 stk, 1 áfpen, 100 mg, 100mg , 1stk | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | Janssen-CilagInternationalN.V. / Vistorhf |
| Iceland | (L04AC16) guselkumab (adm: P) | Tremfya | stl, 1 stk, 1 áfspr, 100 mg, 100mg , 1stk | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Crohn Disease;Colitis, Ulcerative | Janssen-CilagInternationalN.V. / Vistorhf |
| Iceland | (L04AC18) risankizumab (adm: P) | Skyrizi | stl, 2,4 ml, 1 stk, 360 mg, 360mg , 2,4ml | Retail price with vat |
$0-0 |
$0-0 |
Psoriasis;Arthritis, Psoriatic | Vistor-óskráð / Vistorhf |
| Iceland | (L04AD01) ciclosporin (adm: O) | Sandimmun Neoral | mixtúra, 50 ml, 1 glas, 100 mg/ml, 100mg/ml , 50ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | NovartisHealthcareA/S / Vistorhf |
Pages
